KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹18 Cr | ₹20 Cr | ₹41 Cr | ₹21 Cr | ₹42 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹21 Cr |
Mar2020 | ₹42 Cr |
How is Contingent Liabilities of KOPRAN Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | -9.05 | |
Mar2023 | ₹20 Cr | -51.22 | |
Mar2022 | ₹41 Cr | 93.30 | |
Mar2021 | ₹21 Cr | -49.30 | |
Mar2020 | ₹42 Cr | - |
Compare Contingent Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,553.0 Cr | -6.5% | 4.1% | 46.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹447,596.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,695.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,401.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,341.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,198.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -6.5% |
4.1% |
46.3% |
SENSEX | 2% |
4.5% |
25.2% |
You may also like the below Video Courses